Page 40 - manuscript_ijb05590
P. 40
doi:10.3390/cancers13040874
94. Swartz MA, Iida N, Roberts EW, et al. Tumor microenvironment complexity:
emerging roles in cancer therapy. Cancer Res. 2012;72(10):2473-2480.
doi:10.1158/0008-5472.CAN-12-0122
95. Han J, Jeong HJ, Choi J, et al. Bioprinted patient-derived organoid arrays capture
intrinsic and extrinsic tumor features for advanced personalized medicine. Adv Sci
Weinh Baden-Wurtt Ger. 2025;12(20):e2407871. doi:10.1002/advs.202407871
96. Xu K, Huang Y, Wu M, Yin J, Wei P. 3D bioprinting of multi-cellular tumor
microenvironment for prostate cancer metastasis. Biofabrication. 2023;15(3).
doi:10.1088/1758-5090/acd960
97. Xiong Q, Liu T, Ying Y, et al. Establishment of bladder cancer spheroids and
cultured in microfluidic platform for predicting drug response. Bioeng Transl Med.
2024;9(2):e10624. doi:10.1002/btm2.10624
98. Skubal M, Larney BM, Phung NB, et al. Vascularized tumor on a microfluidic
chip to study mechanisms promoting tumor neovascularization and vascular
targeted therapies. Theranostics. 2025;15(3):766-783. doi:10.7150/thno.95334
99. G P, Singh M, Gupta PK, Shukla R. Synergy of microfluidics and nanomaterials:
a revolutionary approach for cancer management. ACS Appl Bio Mater.
2025;8(4):2716-2734. doi:10.1021/acsabm.5c00123
100. Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer.
2013;13(12):871-882. doi:10.1038/nrc3627
101. Abdalla AME, Xiao L, Ullah MW, Yu M, Ouyang C, Yang G. Current Challenges
of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.
Theranostics. 2018;8(2):533-548. doi:10.7150/thno.21674
102. Chen X, Qian H, Qiao H, et al. Tumor-Adhesive and pH-Degradable Microgels
by Microfluidics and Photo-Cross-Linking for Efficient Antiangiogenesis and
Enhanced Cancer Chemotherapy. Biomacromolecules. 2020;21(3):1285-1294.
doi:10.1021/acs.biomac.0c00049
103. Huang K, He Y, Zhu Z, et al. Small, traceable, endosome-disrupting, and
bioresponsive click nanogels fabricated via microfluidics for CD44-targeted
cytoplasmic delivery of therapeutic proteins. ACS Appl Mater Interfaces.
Published online June 3, 2019. doi:10.1021/acsami.9b05827
104. Arduino I, Di Fonte R, Sommonte F, et al. Fabrication of Biomimetic Hybrid
Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor
Efficacy Studies in Glioma Cells. Int J Nanomedicine. 2024;19:13217-13233.
doi:10.2147/IJN.S489872
39
